发明名称 Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
摘要 The present disclosure provides methods of increasing the level of a polypeptide of interest in a mammalian subject by administering a polynucleotide having one or more chemical modifications and a Protein:Cytokine ratio of greater than 100.
申请公布号 US9428535(B2) 申请公布日期 2016.08.30
申请号 US201213644072 申请日期 2012.10.03
申请人 Moderna Therapeutics, Inc. 发明人 de Fougerolles Antonin;Roy Atanu;Schrum Jason P.;Siddiqi Suhaib;Hatala Paul;Bancel Stephane
分类号 C12N15/11;C07H21/02;C12N15/67;A61K48/00 主分类号 C12N15/11
代理机构 Clark & Elbing LLP 代理人 Clark & Elbing LLP
主权项 1. A method of expressing a polypeptide of interest in a mammalian subject comprising administering to said subject an isolated mRNA comprising: (a) a sequence of n number of linked nucleosides, (b) a 5′ UTR, (c) a 3′ UTR, and (d) at least one 5′ cap structure, wherein said isolated mRNA is fully modified with 1-methylpseudouridine, wherein said isolated mRNA, when administered to peripheral blood mononuclear cells provides Protein:Cytokine (P:C) ratios of greater than 100 for TNF-alpha and greater than 100 for IFN-alpha after about eighteen or more hours, and wherein said P:C ratios are higher than those of a corresponding mRNA comprising pseudouridine in place of 1-methylpseudouridine.
地址 Cambridge MA US